Abstract Details

Title Persistence and adherence of fingolimod compared with other disease-modifying therapies for the treatment of multiple sclerosis: a retrospective US claims database analysis

Topic Multiple Sclerosis

Presentation(s) (-)

Poster/Presentation
Number 225

Objective

Background

Design/Methods

Results

Conclusions

Authors/Disclosures
PRESENTER	No disclosure on file
Martin E. Sanders, MD	No disclosure on file
Niklas Bergvall	No disclosure on file
	No disclosure on file
Neetu Agashivala (Novartis Pharmaceutical Corporation)	No disclosure on file
Ashish Pradhan, MD (Genentech)	Dr. Pradhan has received personal compensation for serving as an employee of Genentech. Dr. Pradhan has received stock or an ownership interest from Genetech.
Gorana Capkun	No disclosure on file
	No disclosure on file
	No disclosure on file
	No disclosure on file
Charles Makin	No disclosure on file

��ɫ��

��ɫ��

Abstract Details

��ɫ����

��ɫ����

��ɫ��

��ɫ��